Jana Care

Executive Summary

Jana Care is a Boston-based diagnostics company founded in 2014, focused on connected, at-home testing for chronic disease management. Its platform combines paper-based test strips for key biomarkers (e.g., HbA1c, CRP) with a smartphone-based reader (Aina) to enable affordable remote monitoring. By transmitting results directly to physicians, the company aims to reduce hospital readmissions and facilitate timely telehealth interventions. Targeting the growing chronic disease population, Jana Care addresses the need for cost-effective, decentralized diagnostics. The company's technology has the potential to improve patient outcomes and lower healthcare costs, positioning it as a key player in the remote patient monitoring space. However, as a private company with limited public information, its commercial traction and regulatory status remain unverified. The following conviction score reflects the promising market opportunity balanced against the early-stage risk.

Upcoming Catalysts (preview)

• Q3 2026FDA clearance for expanded biomarker panel (e.g., cardiac markers)60% success
• Q4 2026Strategic partnership with a major health system or telehealth provider50% success
• 2027Series B or later funding round to scale manufacturing and sales70% success